First gene therapy for deadly form of muscular dystrophy gets FDA approval for young kids, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

The FDA OK’d the treatment only for children ages 4 and 5, based on study results showing the therapy helped produce a protein needed for muscle growth, which is missing in boys with the condition., The FDA OK’d the treatment only for children ages 4 and 5, based on study results showing the therapy helped produce a protein needed for muscle growth, which is missing in boys with the condition., , Read More

Leave a Reply

Your email address will not be published.